Baird Upgrades Ncino to Outperform, Announces $35 Price Target

Baird analyst Joe Vruwink upgrades Ncino (NASDAQ:NCNO) from Neutral to Outperform and announces $35 price target.

byBenzinga Newsdesk

December 14, 2022

1 minute read

Baird analyst Joe Vruwink upgrades Ncino (NASDAQ:NCNO) from Neutral to Outperform and announces $35 price target.

Opiant Pharmaceuticals Says To ‘Disregard’ Prior News Of $225M Licensing Agreement; Says Intial Release ‘Contains Incorrect Information

By Benzinga Newsdesk

Today, 10:27 PM

We are advised by Opiant Pharmaceuticals that journalists and other readers should disregard the news release, Opiant Pharmaceuticals and Hikma announce exclusive $225 million commercialisation and license agreement for

OPNT

News

CVS, Rite Aid Say They Are Reviewing Whether To Sell Abortion Pill

By Michael Horton

Today, 10:27 PM

-Dow Jones

CVS

Fear & Greed Index Moves To ‘Greed’ Zone Following Inflation Report

By Lisa Levin

Today, 10:27 PM

The CNN Money Fear and Greed index moved to the "Greed" zone following the release of US inflation data. US stocks closed higher on Thursday after consumer price data showed inflation cooling in December, increasing prospects that the US Federal Reserve might slow interest rate increases.

BAC

Vitalik Buterin Says It’s Time To Change How Ethereum Name Service Domains Are Priced: Here’s Why

By Samyuktha Sriram

Today, 10:27 PM

Ethereum (CRYPTO: ETH) creator Vitalik Buterin thinks a market-based approach should be employed to determine the prices of Ethereum Name Service (ENS) domains.

ETH

Baird Upgrades Ncino to Outperform, Announces $35 Price Target

Related Posts

Opiant Pharmaceuticals Says To ‘Disregard’ Prior News Of $225M Licensing Agreement; Says Intial Release ‘Contains Incorrect Information

CVS, Rite Aid Say They Are Reviewing Whether To Sell Abortion Pill

Fear & Greed Index Moves To ‘Greed’ Zone Following Inflation Report

Vitalik Buterin Says It’s Time To Change How Ethereum Name Service Domains Are Priced: Here’s Why